USP18 and lung cancer: In subsequent studies, engineered repression of USP18/UBP43 (ISG15 deconjugating enzyme) was shown to destabilize PML-RARα, reduce proliferation, and increase apoptosis in acute promyelocytic leukemia and lung cancer cell lines [169,170,171].